Scitara

Global Provider of Lab-Specific iPaaS Solutions

Employees
11–50
Business Model
B2B
Total Funding
$20.0M
Last Round
$15.0M Series BJan 2018
Rounds
2

About

Scitara provides a lab-specific iPaaS platform (DLX) enabling digital transformation of scientific labs through cloud-based data integration and workflow automation.

Summary

Scitara is a Biotech company. It has raised $20.0M in total across 2 rounds, most recently a $15.0M Series B round in Jan 2018. Investors include Northpond Ventures and Flybridge Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AJan 2018
$5.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies